Conclusions: GLP-1 RA use was consistently associated with lower odds of developing SUDs among individuals with type 2 diabetes or obesity
Flood L, Korol SV, Ekselius L, Birnir B, Jin Z
Abbreviations GLP-1: glucagon-like peptide 1 GIP: glucose-dependent insulinotropic polypeptide [Ca 2+ ] i : intracellular Ca 2+ concentrations Adcy: adenylate cyclase CICR: Ca 2+ -induced Ca 2+ release T2D: type 2 diabetes mellitus NOTES
In the years since its approval in 2021, Wegovy, along with its technically only for treating diabetes cousin Ozempic thats often prescribed off-label, have virtually revolutionized weight loss (a remaining wrinkle: Wegovy is extremely expensive and not currently available on insurance.) Officially, some of listed side effects of semaglutide drugs like Wegovy include nausea, vomiting, diarrhea, and constipation
Enter Semaglutide, a weight loss game-changer that's taken the world by storm